RTI International, a leading nonprofit U.S. research institute, has released a study exploring the potential public health concerns associated with vapor emitted from e-cigarettes. The organization’s research paper—titled “Exhaled electronic cigarette emissions: What’s your secondhand exposure?”—examines the toxins in e-cigarette vapors and the impact they could have on people exposed to secondhand “smoke.”
Although the long-term impact of exposure to e-cigarette vapor is still unknown, the study—which was authored by Jonathan Thornburg, Ph.D., director of Exposure and Aerosol Technology at RTI—found that emissions from e-cigarettes contain enough nicotine and other chemicals to cause concern.
Nonusers who are exposed to secondhand vapor are potentially breathing in aerosol particles similar in size to those found in diesel-engine smoke and smoke produced by traditional cigarettes. Because e-cigarettes lack regulation, the type and amount of chemicals and potential toxins they may contain could vary greatly depending on the device being used.
RTI is particularly concerned with the lack of regulation regarding e-cigarettes and the surge in marketing and sales that has occurred as a result. The e-cigarette category experienced annual sales that doubled yearly to $1 billion in 2013, according to RTI.
A study examining the vapor released from Blu Ecigs’ and Skycig’s e-cigarettes in comparison to the smoke emitted by Philip Morris USA’s Marlboro Gold and Imperial Tobacco’s Lambert & Butler cigarettes found that levels of harmful and potentially harmful constituents (HPHCs) in cigarette smoke were 1,500 times higher than the levels found in e-cigarette vapor.
The study—titled “Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air”—was published in the December 2014 issue of Regulatory Toxicology and Pharmacology. According to proponents of vapor product use, the study lends credence to the belief that, although the long-term effects of inhaling the propylene glycol and glycerin found in e-cigarette vapor are not yet known, such products provide a safer alternative to smoking combustible cigarettes.
According to the study, the e-cigarettes tested contained and delivered mostly glycerin and/or propylene glycol and water, and emitted an aerosol nicotine content that was 85 percent lower than the cigarette smoke nicotine content levels. The study also found the levels of HPHCs to be consistent with the air blanks—at <2 μg/puff—and no significant contribution of tested HPHC classes was found for the e-cigarettes tested. The e-cigarettes and combustible cigarettes in the study were tested on a smoking machine to compare the amount of nicotine delivery and the relative yields of chemical constituents.
Bxpression of Long Beach, California, USA, is expanding into Europe, with offices in Prague and Paris. Blackcat Europe will make its debut at the Inter-Tabac tradeshow in Dortmund, Germany, on Sept. 19-21. The company will exhibit in hall 5, booth number 5.D10
Anatole Soulier serve as director of sales and marketing for Blackcat Europe.
“We are very excited with our expansion into the European market with our Blackcat E-cig products,” says CEO Mark Leafstedt. “The European market is expanding at a very rapid pace and together with the Blackcat Europe team, headed by Anatole, we intend to bring our products to this part of the world very quickly.”
“I am very pleased to be a part of the blackcat team and together with my team plan to expand it throughout Europe,” said Soulier.
Blackcat Europe will carry the full line of blackcat products, including disposable e-cigarettes and e-cigars, vaporizers, mods and accessories.
For more information, visit www.blackcatecig.com
Johnson Creek Enterprises, the leading manufacturer of e-liquid in the U.S., has teamed up with Republic Tobacco, the nation’s largest distributor of roll-your-own and make-your-own tobacco products and accessories, to distribute Johnson Creek’s e-cigarette hardware and e-liquids nationally in the U.S.
“This is a perfect fit for both of our companies,” says Christian Berkey, Johnson Creek’s founder and CEO. Steve Sandman, president of Republic Tobacco agrees. “Both retailers and wholesalers have been waiting for a reputable company to supply this growing category,” he says. “Our customers should be very pleased that Republic is stepping into the forefront of the ‘e’ category with such an outstanding producer as Johnson Creek.”
Johnson Creek was first company in the U.S. vapor industry to produce and manufacture e-liquid for e-cigarettes. It was also the first company to use child resistant caps, plastic shrink-wrapped banding, and to list ingredients on all bottles.
Altria Group’s NuMark subsidiary has acquired the e-vapor business Green Smoke for $110 million in cash plus up to $20 million in incentive payments, reports Wells Fargo Securities.
Posting $40 million revenue in 2013, the majority of Green Smoke’s sales are online in the U.S. The company’s retail sales in convenience stores were $3.9 million last year, according to Nielsen, representing a 0.8 percent market share.
According to Wells Fargo, Green Smoke presents an opportunity for Altria to develop a portfolio of e-vapor brands to complement its existing MarkTen e-vapor product. Green Smokes products are bigger and have stronger batteries than MarkTens, and they don’t look like traditional cigarettes.
Wells Fargo believes Altria can leverage its sales force, retailer relationships and marketing expertise to quickly bring broader distribution to Green Smoke.
Philip Morris International and Altria Group have established a strategic framework to commercialize reduced-risk products and e-cigarettes. Under the terms of a set of licensing, supply and cooperation agreements, Altria will make available its e-cigarette products exclusively to PMI for commercialization outside the United States and PMI will make available two of its candidate reduced-risk tobacco products exclusively to Altria for commercialization in the United States.
The companies expect PMI’s products in the U.S. to be regulated as Modified Risk Tobacco Products. Any commercialization would be subject to Food and Drug Administration (FDA) authorization.
The agreements also provide for cooperation on the scientific assessment and regulatory engagement and authorization related to these products with the FDA, and for a similar framework for e-cigarettes with the relevant regulatory authorities in international markets. In addition, the agreements provide for the sharing of improvements to the existing generation of products.
“PMI firmly believes that reduced-risk tobacco products, as well as e-cigarettes, represent an important step toward achieving the public health goal of harm reduction, a potential paradigm shift for the industry and a significant growth opportunity for the company,” said PMI CEO André Calantzopoulos.
“Further to our plans for international test market introduction of our candidate reduced-risk products as of the second-half of 2014, this agreement establishes a roadmap for commercialization in the U.S., subject to FDA authorization. At the same time, it provides us with a platform to accelerate our entry into international e-cigarette markets while we continue to develop future versions,”